BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 20503445)

  • 1. Clinical features of hepatitis B virus-related hepatocellular carcinoma.
    Ishikawa T
    World J Gastroenterol; 2010 May; 16(20):2463-7. PubMed ID: 20503445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention and surveillance of hepatitis B virus-related hepatocellular carcinoma.
    Liaw YF
    Semin Liver Dis; 2005; 25 Suppl 1():40-7. PubMed ID: 16103980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B viral load affects prognosis of hepatocellular carcinoma.
    Yu SJ; Kim YJ
    World J Gastroenterol; 2014 Sep; 20(34):12039-44. PubMed ID: 25232241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The direct and indirect roles of HBV in liver cancer: prospective markers for HCC screening and potential therapeutic targets.
    Ringelhan M; O'Connor T; Protzer U; Heikenwalder M
    J Pathol; 2015 Jan; 235(2):355-67. PubMed ID: 25196558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perioperative antiviral therapy for chronic hepatitis B-related hepatocellular carcinoma.
    Wei Q; Xu X; Ling Q; Zhou B; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2013 Jun; 12(3):251-5. PubMed ID: 23742769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors predicting occurrence and prognosis of hepatitis-B-virus-related hepatocellular carcinoma.
    Han YF; Zhao J; Ma LY; Yin JH; Chang WJ; Zhang HW; Cao GW
    World J Gastroenterol; 2011 Oct; 17(38):4258-70. PubMed ID: 22090781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of antiviral therapy on post-hepatectomy outcome for hepatitis B-related hepatocellular carcinoma.
    Chong CC; Wong GL; Lai PB
    World J Gastroenterol; 2014 May; 20(20):6006-12. PubMed ID: 24876723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-viral therapy to reduce recurrence and improve survival in hepatitis B virus-related hepatocellular carcinoma.
    Ishikawa T
    World J Gastroenterol; 2013 Dec; 19(47):8861-6. PubMed ID: 24379608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of hepatocellular carcinoma in hepatitis B virus infection.
    Lim SG; Mohammed R; Yuen MF; Kao JH
    J Gastroenterol Hepatol; 2009 Aug; 24(8):1352-7. PubMed ID: 19702903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B Virus Pre-S Mutants as Biomarkers and Targets for the Development and Recurrence of Hepatocellular Carcinoma.
    Teng CF; Wu HC; Su IJ; Jeng LB
    Viruses; 2020 Aug; 12(9):. PubMed ID: 32859114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review article: the prevention of hepatitis B-related hepatocellular carcinoma.
    Lin CL; Kao JH
    Aliment Pharmacol Ther; 2018 Jul; 48(1):5-14. PubMed ID: 29722445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncogenic viruses and hepatocellular carcinoma.
    Ben Ari Z; Weitzman E; Safran M
    Clin Liver Dis; 2015 May; 19(2):341-60. PubMed ID: 25921667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of recurrence in hepatitis B-related hepatocellular carcinoma: impact of viral load in late recurrence.
    Hoshida Y
    J Hepatol; 2009 Nov; 51(5):842-4. PubMed ID: 19748698
    [No Abstract]   [Full Text] [Related]  

  • 14. Secondary prevention of hepatitis B virus-related hepatocellular carcinoma with current antiviral therapies.
    Choi J; Lim YS
    Kaohsiung J Med Sci; 2021 Apr; 37(4):262-267. PubMed ID: 33502828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiviral therapy improves post-operative survival outcomes in patients with HBV-related hepatocellular carcinoma of less than 3 cm - A retrospective cohort study.
    Wang ZY; Tao QF; Wang ZH; Lin KY; Huang G; Yang Y; Zhou WP; Lau WY
    Am J Surg; 2020 Apr; 219(4):717-725. PubMed ID: 31266631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chronic hepatitis B].
    Thimme R; Spangenberg HC; Blum HE
    Dtsch Med Wochenschr; 2008 Jan; 133(4):135-8. PubMed ID: 18197589
    [No Abstract]   [Full Text] [Related]  

  • 17. Suppressive effects of entecavir on hepatitis B virus and hepatocellular carcinoma.
    Jin YJ; Shim JH; Lee HC; Yoo DJ; Kim KM; Lim YS; Suh DJ
    J Gastroenterol Hepatol; 2011 Sep; 26(9):1380-8. PubMed ID: 21884247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of hepatitis B virus genotype mixture, subgenotypes C2 and B2 on hepatocellular carcinoma: compared with chronic hepatitis B and asymptomatic carrier state in the same area.
    Yin J; Zhang H; Li C; Gao C; He Y; Zhai Y; Zhang P; Xu L; Tan X; Chen J; Cheng S; Schaefer S; Cao G
    Carcinogenesis; 2008 Sep; 29(9):1685-91. PubMed ID: 18192693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic hepatitis B and hepatocellular carcinoma.
    McClune AC; Tong MJ
    Clin Liver Dis; 2010 Aug; 14(3):461-76. PubMed ID: 20638025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B Virus Pregenomic RNA in Hepatocellular Carcinoma: A Nosological and Prognostic Determinant.
    Halgand B; Desterke C; Rivière L; Fallot G; Sebagh M; Calderaro J; Bioulac-Sage P; Neuveut C; Buendia MA; Samuel D; Féray C
    Hepatology; 2018 Jan; 67(1):86-96. PubMed ID: 28802063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.